Ignite Creation Date:
2025-12-24 @ 9:32 PM
Ignite Modification Date:
2026-01-02 @ 7:44 AM
Study NCT ID:
NCT06130332
Status:
RECRUITING
Last Update Posted:
2023-11-14
First Post:
2023-11-01
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Neoadjuvant Tirellizumab Combined With Chemotherapy for Early Oral Squamous Cell Carcinoma(HNC-SYSU-004)
Sponsor:
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Organization: